Frequency and antimicrobial susceptibility of Acinetobacter species isolated from blood samples of paediatric patients

Pakistan Journal of Medical Sciences

Volumn 28, Issue 3, 2012, Pages 363-366

  Javed, Ayisha ^a   Zafar, Aizza ^a   Ejaz, Hasan ^a   Zubair, Muhammad ^a  

^a CHILDREN S HOSPITAL   (Pakistan)

Author keywords

Acinetobacter species; Antimicrobial susceptibility; Paediatric blood samples

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CARBAPENEM DERIVATIVE; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON;

ACINETOBACTER; ANALYTICAL EQUIPMENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOOD CULTURE; BLOOD SAMPLING; CHILD; CROSS-SECTIONAL STUDY; DISK DIFFUSION; DRUG EFFICACY; FEMALE; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; MALE; NONHUMAN; OBSERVATIONAL STUDY; PAKISTAN; PEDIATRIC HOSPITAL; SEX DIFFERENCE;

EID: 84861893327     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Kilic A, Li H, Mellmann A, Basustaaoglu CA, Kul M, Senses S, et al. Acinetobacter septicus sp. nov. association with a nosocomial outbreak of bacterimia in neonatal intensive care unit. J Clin Microbiol 2008;46(3):902-908.
2. Bergogne-Berezin E, Towner JK. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbial rev 1996;148-165.
3. Antunes LC, Carattoli A, Visca P. Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity. J Clin Microbiol 2011;269-273.
4. Wisplinghoff H, Edmond MB, Pfaller MA, Jones RA, Wenzel RP, Seifert H. Nosocomial Bloodstream infections caused by Acinetobacter species in United states hospitals: clinical features and molecular epidemiology. Clin Infect Dis 2000;3:690-697.
5. Metan G, Sariguzal F and Sumerkan B. Factors influencing survival in patients with multidrug resistant Acinetobacter baumanii bacterimia. EFIM 2009;20(5):540-544.
6. Giamarellous H, Antomiadou A, Kanellakopoulu K. Acinetobacter baumannii: a universal threat to public health. Int J Antimicrob AG 2008;32:106-119.
7. Cheesbrough M. District laboratory practice in tropical countries (2) Cambridge University press, United Kingdom. 2000: 124-143.
8. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility tests 20th ed. approved standard, CLSI document M100-S20, vol. 30. 2010. Wayne, PA: CLSI.
9. Singhi S, Ray P, Mathew JL, Jayashree M, Dhanalakshmi. Nosocomial bloodstream infection in a pediatric intensive care unit, Indian J Pediatr 2008;75(1):25-30.
10. Lee N, Chang TC, Wu C, Chang C, Lee H, Chen P, Lee C, Ko NY, Ko W. Clinical manifestations, antimicrobial therapy and prognostic factors of monomicrobial Acinetobacter baumanii complex bacteremia. J Infection 2010;61(3):219-227.
11. Parshant K, Badrinth S. Nosocomial infections due to Acinetobacter species: Clinical findings, risk and prognostic factors. Indian J Med Microbiol 2006;24:39-44.
12. Diez AID, Perez MAB, Bouza JME, Gomez AA, Rodriguez PG, Gomez MAM, Domingo AO, Torres AO. Susceptibility of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex to imipenem, meropenem, sulbactem and colistin. Int J Antimicrob AG 2004;23(5):487-493.
13. Eddie GCU, Mariano N, Rahal JJ. Interaction of sulbactam, clavulanic acid and tazobactam with penicillin-binding proteins of imipenem-resistant and susceptible Acinetobacter baumannii. FEMS Microbiol lett 1995;125(2-3):193-197.
14. Carreto E, Barbarini D, Dijkshroon L, Reijden TJK, Brisse S, Passet V, Farina C. Widespread carbepenem resistant Acinetobacter baumanii clones in Italian hospitals revealed by a multicancer study. MEEGID 2011;11(6):1319-1326.
15. Casellas JM, Tome G, Bantar C, Bertolini P, Blazquez N, Borda N, et al. Argentinean collaborative multicancer study on the in vitro comparative activity of piperacillintazobactem against selected bacterial isolates recovered from hospitalized patients. Diagn Micr Infec Dis 2003;47(3):527-537.
16. Sader HS, Jones RN, Andrade-Baiocchi S, Biedenbach DJ. Four-years evalution of frequency of occurance and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin medical centers. Diagn Micro Infec Dis 2003;44(3):273-280.
17. Chang SC, Chen YC, Luh KT, Hsieh WC. In vitro activities of antimicrobial agents, alone and in combination, against Acinetobacter baumannii isolated from blood. Diagn Micro Infec Dis 1995;23(3):105-110.
18. McGrath JE, Chopra T, Haq NA, Preney K, Koo-Winston K, Basim I, Keith S. An outbreak of carbapenem resistant Acinetobacter baumannii infections in a neonatal intensive care unit: investigation and control. Infect Cont Hosp Ep 2011;32(1):34-41.